BDH1 Antibodies

Santa Cruz Biotechnology features a diverse variety of BDH1 monoclonal antibodies for research focused on understanding BDH1 protein function. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BDH1, or 3-hydroxybutyrate dehydrogenase 1, plays a crucial role in the metabolism of ketone bodies, particularly in the conversion of acetoacetate to β-hydroxybutyrate. The enzyme is essential for energy production during periods of fasting or low carbohydrate intake, making it significant in metabolic studies and conditions such as diabetes and obesity. BDH1 research continues to reveal important insights about metabolic regulation and energy homeostasis. Understanding BDH1 function can illuminate new pathways in metabolic disorders and potential therapeutic approaches. Investigating BDH1 activity provides valuable information about cellular responses during metabolic stress. Research using BDH1 monoclonal antibodies helps expand scientific understanding of fundamental metabolic processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance metabolic disease research and therapeutic development.